Concepedia

Author

Peter Marks

United States Food and Drug AdministrationORCID

Also Known As

Gilbert ‘Lynn’ Marks, I. Malátová, Kralovics, Marks, Peter, Michael Iademarco, P Marks, P W Marks, P. Marks, P. W. Marks, P.W Marks

201

Publications

9.5K

Citations

40

H-Index

199

Concepts

All Affiliations

United States Food and Drug AdministrationBrigham and Women's HospitalCenter for Biologics Evaluation and ResearchHarvard UniversityYale University
PM

About

Peter Marks is an author at United States Food and Drug Administration specializing in medicine, public health, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

43

4.8K

2

Natural Sciences

6

6

696

3

Health Sciences

4

4

657

4

Engineering

3

3

2.2K

5

Nursing

1

1

42

Peter Marks

×

80

Publications

8.1K

Citations

37

H-Index

YearCitations

Real-World Evidence — What Is It and What Can It Tell Us?

Rachel E. Sherman, Steven A. Anderson, Gerald J. Dal Pan,

New England Journal of Medicine

2016

1.9K

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld,

New England Journal of Medicine

2021

539

Early safety indicators of COVID-19 convalescent plasma in 5000 patients

Michael J. Joyner, R. Scott Wright, DeLisa Fairweather,

Journal of Clinical Investigation

2020

478

Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background

Hiroaki Onda, A. Lueck, Peter Marks,

Journal of Clinical Investigation

1999

387

Rac1 Deletion in Mouse Neutrophils Has Selective Effects on Neutrophil Functions

Michael Glogauer, Christophe C. Marchal, Fei Zhu,

The Journal of Immunology

2003

325

Clarifying Stem-Cell Therapy’s Benefits and Risks

Peter Marks, Celia Witten, Robert M. Califf

New England Journal of Medicine

2016

276

A randomised comparison of deferasirox<i>versus</i>deferoxamine for the treatment of transfusional iron overload in sickle cell disease

Elliott Vichinsky, Onyinye Onyekwere, John B. Porter,

British Journal of Haematology

2006

270

Transient increases in cytosolic free calcium appear to be required for the migration of adherent human neutrophils [published erratum appears in J Cell Biol 1990 Mar;110(3):861]

Peter Marks

The Journal of Cell Biology

1990

260

Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy

Nicole Verdun, Peter Marks

New England Journal of Medicine

2024

237

Cdc42 is required for PIP2-induced actin polymerization and early development but not for cell viability

F. Chen, Le Ma, Maria Carla Parrini,

Current Biology

2000

219

Page 1